The poster argues that many people calling their GLP-1 use microdosing are really on the standard starting amount. A short social take, not new information.
Recap by typeshit. Post by Facebook on Facebook.
Dr. Nadolsky, an obesity medicine doctor, gives his take on a recent GLP-1 warning in a short clip. Tap through to see which warning he means.
2:12
A short explainer on the experimental injection people call Reta, covering why it went viral and what is known so far about its safety.
A nationwide recall now covers a GLP-1 injectable. The full story names the affected medication and explains why it was pulled.
32:25
The channel walks through FDA inspection findings of mold at suppliers and what people taking GLP-1 medications should watch for.
The post notes that much of the worry over semaglutide and cancer traces back to animal studies, and that a label warning differs from evidence of harm in people.
Dissolving strips are showing up in the peptide market. The Bee asks the FDA and researchers whether they are safe and actually work.
Loading…